CEACAM5 and chronic kidney disease: According to the inclusion and exclusion criteria, we totally included 114 patients with COVID-19 (46 death cases and 68 discharged cases) in our study, with two patients with cancers, one with chronic kidney disease, and one without CEA levels excluded.